We are live on ! Find out more
SFG

SVB Financial Group Portfolio holdings

AUM $434K
1-Year Est. Return 277.67%
This Fund
S&P 500
This Quarter Est. Return
+56.15%
1 Year Est. Return
+277.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$52.3M
AUM Growth
+$15.7M
Cap. Flow
+$995K
Cap. Flow %
1.9%
Top 10 Hldgs %
94.43%
Holding
34
New
4
Increased
1
Reduced
9
Closed
6

Top Buys

Rank Stock Value
1
OBIO icon
Orchestra BioMed
OBIO
+$1.47M
2
GPCR icon
Structure Therapeutics
GPCR
+$831K
3
PATH icon
UiPath
PATH
+$680K
4
FROG icon
JFrog
FROG
+$447K
5
MVLA
Movella Holdings Inc. Common Stock
MVLA
+$327K

Top Sells

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$924K
2
OWLT icon
Owlet
OWLT
+$493K
3
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$394K
4
KROS icon
Keros Therapeutics
KROS
+$223K
5
SLNA
Selina Hospitality PLC Ordinary Shares
SLNA
+$136K

Sector Composition

Rank Sector Weight
1 Financials 59.44%
2 Technology 21.72%
3 Healthcare 16.18%
4 Industrials 1.4%
5 Consumer Discretionary 0.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COIN icon
1
Coinbase
COIN
$39.3B
$27.5M 52.61%
406,973
– –
OKTA icon
2
Okta
OKTA
$25.1B
$8.61M 16.48%
99,872
-12,140
-11% -$924K
ROOT icon
3
Root
ROOT
$747M
$3.53M 6.76%
783,012
– –
OBIO icon
4
Orchestra BioMed
OBIO
$246M
$2.49M 4.76%
+127,068
New +$1.47M
AXSM icon
5
Axsome Therapeutics
AXSM
$11B
$2.09M 3.99%
33,849
– –
FROG icon
6
JFrog
FROG
$10.3B
$1.88M 3.59%
95,251
+20,053
+27% +$447K
GPCR icon
7
Structure Therapeutics
GPCR
$3.65B
$841K 1.61%
+35,353
New +$831K
DICE
8
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$833K 1.59%
29,066
-13,292
-31% -$394K
CMAX
9
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$801K 1.53%
10,000
– –
PATH icon
10
UiPath
PATH
$7.1B
$791K 1.51%
+45,029
New +$680K
PL icon
11
Planet Labs
PL
$8.33B
$676K 1.29%
172,097
– –
ROVR
12
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$478K 0.91%
105,534
– –
MLTX icon
13
MoonLake Immunotherapeutics
MLTX
$1.53B
$346K 0.66%
16,173
– –
CGEM icon
14
Cullinan Oncology
CGEM
$1.09B
$207K 0.4%
20,274
-6,758
-25% -$74.5K
GBIO
15
DELISTED
Generation Bio
GBIO
$174K 0.33%
4,040
-1,252
-24% -$60.6K
FIRY
16
Firy Inc
FIRY
$151M
$162K 0.31%
13,697
– –
CRBU icon
17
Caribou Biosciences
CRBU
$162M
$147K 0.28%
27,619
-19,432
-41% -$121K
KLRS
18
Kalaris Therapeutics
KLRS
$101M
$136K 0.26%
1,496
-374
-20% -$47.6K
PACB icon
19
Pacific Biosciences
PACB
$367M
$119K 0.23%
10,249
– –
KNTE
20
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$97.4K 0.19%
15,588
-7,794
-33% -$47.5K
MVLA
21
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$75.6K 0.14%
+55,570
New +$327K
PRDS
22
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$75.1K 0.14%
56,901
-20,979
-27% -$34.3K
ELDN icon
23
Eledon Pharmaceuticals
ELDN
$269M
$63.6K 0.12%
26,942
-13,671
-34% -$36.6K
NOGN
24
DELISTED
Nogin, Inc. Common Stock
NOGN
$57.6K 0.11%
21,220
– –
ML
25
DELISTED
MoneyLion Inc.
ML
$42.3K 0.08%
2,486
– –
1
2

Similar funds

RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
CBFP
Cedar Brook Financial Partners Cleveland, Ohio $698K AUM 46.64% 1-Year Est. Return
BP
BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return
SLA
SWaN & Legend Advisors Leesburg, Virginia $841K AUM 23.47% 1-Year Est. Return
SG
Stagwell Group Miami Beach, Florida $913K AUM 49.68% 1-Year Est. Return
AFG
AFS Financial Group Bethesda, Maryland $1.15M AUM 23.97% 1-Year Est. Return
K
Kemper Chicago, Illinois $1.2M AUM 20.64% 1-Year Est. Return
MIG
MGG Investment Group New York $1.36M AUM 20.76% 1-Year Est. Return

SVB Financial Group's Q1 2023 Portfolio in Review

As of Q1 2023, SVB Financial Group held 34 positions worth $52.3M, up 43% from $36.6M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

SVB Financial Group's Q1 2023 filing shows 4 new, 1 increased, 9 reduced and 6 closed positions. Its largest new stake was Orchestra BioMed: 127,068 shares worth $2.49M. The largest sale was Okta, an estimated $924K.

By sector, the portfolio is most concentrated in Financials at 59% of assets, up from 49% a quarter earlier, followed by Technology and Healthcare.

  • SVB Financial Group's largest Q1 2023 buy was Orchestra BioMed: 127,068 shares worth $2.49M.
  • SVB Financial Group added most to JFrog in Q1 2023, an estimated $447K increase.
  • SVB Financial Group's biggest Q1 2023 reduction was Okta, cutting an estimated $924K.
  • SVB Financial Group fully exited Owlet in Q1 2023, selling an estimated $493K.
  • SVB Financial Group's ten largest holdings make up 94% of its $52.3M portfolio in Q1 2023.
  • SVB Financial Group opened 4 new positions and closed 6 in Q1 2023.
  • SVB Financial Group's portfolio value rose 43% quarter-over-quarter to $52.3M.

Based on SVB Financial Group's 13F filing for Q1 2023, filed 15 May 2023.